Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$191.17 - $325.63 $20,837 - $35,493
109 Added 9.95%
1,205 $392,000
Q4 2023

Feb 14, 2024

BUY
$160.99 - $215.69 $176,445 - $236,396
1,096 New
1,096 $208,000
Q2 2023

Aug 14, 2023

BUY
$223.05 - $302.68 $169,071 - $229,431
758 New
758 $216,000
Q3 2022

Oct 24, 2022

BUY
$195.21 - $310.53 $142,698 - $226,997
731 New
731 $203,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Eqis Capital Management, Inc. Portfolio

Follow Eqis Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.